Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
The service can also be used by physicians to send medical images to other facilities. All they need do is log onto the URL, upload images, then advise physicians at the facility where they are referring their patients that the images are available for downloading.
SeeMyRadiology.com can be branded with an imaging site’s name to enhance recognition, according to AccelaRAD, formerly known as Neurostar, which is framing the application as a major step toward realizing the benefits of comprehensive electronic medical records (EMRs). Developed in collaboration with The Ohio State University Medical Center in Columbus and Piedmont Hospital in Atlanta, SeeMyRadiology.com includes a toolkit enabling seamless standards-based image integration with a full range of PACS, EMRs and personal health records systems.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.